InflaRx NV (IFRX)
InflaRx Market Cap : 308.00M for Sept. 11, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 308.00M |
| September 10, 2026 | 302.10M |
| September 09, 2026 | 308.00M |
| September 08, 2026 | 319.79M |
| September 04, 2026 | 327.16M |
| September 03, 2026 | 328.63M |
| September 02, 2026 | 337.47M |
| September 01, 2026 | 318.32M |
| August 31, 2026 | 313.89M |
| August 28, 2026 | 328.63M |
| August 27, 2026 | 334.53M |
| August 26, 2026 | 356.63M |
| August 25, 2026 | 362.53M |
| August 24, 2026 | 302.10M |
| August 21, 2026 | 309.47M |
| August 20, 2026 | 297.68M |
| August 19, 2026 | 312.42M |
| August 18, 2026 | 321.26M |
| August 17, 2026 | 305.05M |
| August 14, 2026 | 300.63M |
| August 13, 2026 | 296.21M |
| August 12, 2026 | 296.21M |
| August 11, 2026 | 294.74M |
| August 10, 2026 | 288.84M |
| August 07, 2026 | 271.16M |
| Date | Value |
|---|---|
| August 06, 2026 | 253.47M |
| August 05, 2026 | 260.84M |
| August 04, 2026 | 262.32M |
| August 03, 2026 | 126.51M |
| July 31, 2026 | 122.90M |
| July 30, 2026 | 124.34M |
| July 29, 2026 | 119.28M |
| July 28, 2026 | 122.18M |
| July 27, 2026 | 122.90M |
| July 24, 2026 | 125.79M |
| July 23, 2026 | 125.07M |
| July 22, 2026 | 130.13M |
| July 21, 2026 | 130.85M |
| July 20, 2026 | 131.57M |
| July 17, 2026 | 134.10M |
| July 16, 2026 | 138.08M |
| July 15, 2026 | 146.03M |
| July 14, 2026 | 145.31M |
| July 13, 2026 | 148.92M |
| July 10, 2026 | 148.20M |
| July 09, 2026 | 148.92M |
| July 08, 2026 | 156.15M |
| July 07, 2026 | 153.26M |
| July 06, 2026 | 152.54M |
| July 02, 2026 | 161.94M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| MediGene AG | 1.474M |
| BioNTech SE | 24.30B |
| Immatics NV | 1.202B |
| Beam Therapeutics, Inc. | 2.477B |
| Kymera Therapeutics, Inc. | 9.517B |
Market Cap Related Metrics
| PS Ratio | 2345.49 |
| Price to Book Value | 1.843 |
| Price | 2.09 |
| Earnings Yield | -31.02% |